Epilek - analogs
Components: Epirubicin |
|||||||||
Pharmgroups: Antitumor antibiotics || Anthracyclines and related compounds |
|||||||||
Prices in pharmacies: — Instructions Epilek | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Diltiazem retard ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
≈100% | Dangerous 🔍 Epirubicin-Ebewe | 2.8-32.8€ |
≈100% | Dangerous 🔍 Vero-Epirubicin | 5.3-19.5€ |
≈100% | Dangerous 🔍 Farmorubicin rapid dissolution | 11.7€ |
≈100% | Dangerous 🔍 Epirubicin | — |
≈100% | Dangerous 🔍 Epirubicin hydrochloride | — |
≈100% | Dangerous 🔍 Farmorubicin | — |
≈100% | Dangerous 🔍 Episindan | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 63% 2.6-7.7€ Doxorubicin-LANS Negative 🔍 [Doxorubicin]
- 63% — Doxorubicin-Ferein Negative 🔍 [Doxorubicin]
- 63% 6.9€ Doxorubicin-Teva Negative 🔍 [Doxorubicin]
- 63% — Doxorubicin hydrochloride Negative 🔍 [Doxorubicin]
- 63% — Doxorubicin Lachema Negative 🔍 [Doxorubicin]
- 63% — Rastocin Negative 🔍 [Doxorubicin]
- 63% — Никорубин Negative 🔍 [Doxorubicin]
- 63% — Доксофос Negative 🔍 [Doxorubicin]
- 62% 43.5-44€ Oncotrone neutral [Mitoxantrone]
- 60% — Doxolem Negative 🔍 [Doxorubicin]
- 60% 970€ Caelyx Negative 🔍 [Doxorubicin]
- 60% 3.5€ Adriblastina rapid dissolution Negative 🔍 [Doxorubicin]
- 59% — Mitoxantron AWD 25 neutral [Mitoxantrone]
- 59% — Mitoxantron AWD neutral [Mitoxantrone]
- 59% — Mitolek neutral [Mitoxantrone]
- 59% — Mitoxantron neutral [Mitoxantrone]
- 59% — Mitoxantron hydrochloride neutral [Mitoxantrone]
- 59% 9.9€ Doxorubicin-Ebewe Negative 🔍 [Doxorubicin]
- 58% — Mitomycin C neutral [Mitomycin]
- 58% 23.4€ Mitoxantron-LANS neutral [Mitoxantrone]
- 58% — Mutamycin neutral [Mitomycin]
- 58% 249€ Mitomycin-C Kyowa neutral [Mitomycin]
- 58% — Mitomycin neutral [Mitomycin]
- 58% — Митомицин-деко neutral [Mitomycin]
- 57% — Mitomycin-LANS neutral [Mitomycin]
- 56% — Doxorubifer Negative 🔍 [Doxorubicin]
- 54% 38€ Vero-Mitomycin neutral [Mitomycin]
- 54% — Novantrone neutral [Mitoxantrone]
- 54% — Adriblastina NovaMedica rapid dissolution Negative 🔍 [Doxorubicin]
- 54% — Doxorubicin-RONC Negative 🔍 [Doxorubicin]
- 54% 2.6€ Doxorubicin Negative 🔍 [Doxorubicin]
- 54% — Doxorubicin-DEKO Negative 🔍 [Doxorubicin]
- 53% 3.6€ Sindroxocin Negative 🔍 [Doxorubicin]
- 49% — Bleomycetin neutral [Bleomycin]
- 49% 15.7€ Bleocin neutral [Bleomycin and more 1Bleomycin sulfate]
- 49% — Bleomycetin hydrochloride neutral [Bleomycin]
- 49% 12.9€ Vero-Bleomycin neutral [Bleomycin]
- 46% 2.4€ Fytosid neutral [Etoposide]
- 45% — UFT neutral [Tegafur+Uracil and more 1Tegafur]
- 44% — Chlorbutin tablets neutral [Chlorambucil]
- 44% — Лорамил neutral [Chlorambucil]
- 44% — Chlorbutin neutral [Chlorambucil]
- 44% 13.8-28.7€ Leukeran neutral [Chlorambucil]
- 42% — Fluoro-uracil Roche neutral [Fluorouracil]
- 42% 74.6-74.7€ Ftorafur neutral [Tegafur]
- 42% — Phthoruracil neutral [Fluorouracil]
- 42% — Fivoflu neutral [Fluorouracil]
- 42% — Ftorafur solution for injections neutral [Fluorouracil]
- 41% 0.7€ Fluorouracil-Teva neutral [Fluorouracil]
- 41% — Nidran neutral [Nimustine]
Learn more about the selection of analogues
- The drug has «Epilek» 10 full analogs, the cheapest - Epirubicin-Ebewe (2.8-32.8€); 51 analog by action, the most similar - Doxorubicin-LANS (2.6-7.7€).
- Medical online service has selected the best substitutes for Epilek based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Epilek to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.